CommunityRx-Cardiovascular Disease: Implementation of the HealtheRx to Reduce Health Inequity in Rural Eastern North Carolina
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 308
- 试验地点
- 4
- 主要终点
- Change in participant self-efficacy for finding community resources
研究概览
简要总结
The goal of this single arm pre-test post-test design study is to test the impact of providing patients with information about community-based resources to address health-related social needs and cardiometabolic health in rural African American patients. The main question it aims to answer is:
• What is the effectiveness of community resource information on patient self-efficacy to use community resources?
Participants will be given:
- A personalized "HealtheRx" resource with information about community resources related to food, housing, utility support, transportation, and crisis support. The HealtheRx is personalized for patients based on their age and zip code.
- Access to a community resource navigator for support with using the HealtheRx upon request
- 2 text messages with reminders about the HealtheRx and access to the community resource navigator
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 2 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •African American
- •age 2 or older
- •Have at least one cardiometabolic condition:
- •Overweight (BMI greater than or equal to 25 kg/m^2);
- •Obesity (BMI greater than or equal to 30 kg/m^2);
- •ICD-9 or 10 diagnostic code for overweight or obesity
- •Adult prehypertension (SBP 120 to 129 and DBP greater than 80 mmHg);
- •Adult hypertension (SBP greater than or equal to130 or DBP = 80 mmHg);
- •Pediatric Prehypertension (SBP or DBP greater than or equal to 90th but <95th percentile)
- •Pediatric Hypertension (SBP or DBP greater than or equal to 95th percentile);
- •ICD-9 or 10 diagnostic code for hypertension
- •Adult and Pediatric Prediabetes (Fasting glucose 100-125 mg/dL or OGTT 140-199 mg/dL)
- •Adult and Pediatric Diabetes (FPG greater than or equal to126 mg/dL (7.0 mmol/L) or OGTT greater than or equal to 200 mg/dL (11.1mmol/L) or HgbA1C greater than or equal to 6.5);
- •ICD-9 or 10 diagnostic code for diabetes, pre-diabetes or elevated glucose, or gestational diabetes;
- •Adult and Pediatric Total cholesterol (>200mg/dL; LDL >130mg/dL; HDL < 35 mg/dL; TG greater than or equal to150mg/dL);
- •ICD-9 or 10 diagnostic code for hyperlipidemia
排除标准
- •Unable to read, speak or understand English
- •Unable to receive text message or email communications
- •Living in the same household as someone already enrolled in the CRx-CVD study
- •Adults with limited life expectancy (e.g., advanced cancer, end stage liver disease, hospice)
- •Adults receiving treatment for cancer
- •Adults living in skilled nursing facilities
- •Dementia/other significant cognitive impairment
研究组 & 干预措施
Intervention Group
This group will receive the intervention
干预措施: HealtheRx (Other)
结局指标
主要结局
Change in participant self-efficacy for finding community resources
时间窗: Baseline, up to 6 months
Change in self-efficacy for finding community resources is measured using one item constructed from Bandura's Self-Efficacy Scale which asks, "How confident are you in your ability to find resources in your community that help you manage your health?" Responses will be assessed on a 5-point Likert scale ranging from 1= "not at all confident" to 5= "completely confident." Lower scores indicate lower levels of confidence, and higher scores indicate higher levels of confidence. We will report counts with percentages pre- and post-intervention.
次要结局
- Change in participant knowledge of community resources(Baseline, up to 6 months)
- Change in participant utilization of community resources(Baseline, up to 6 months)